ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling

Li, Jia-Xin; Li, Run-Ze; Sun, Ao; Zhou, Hua; Neher, Erwin; Yang, Jia-Shun; Huang, Ju-Min; Zhang, Yi-Zhong; Jiang, Ze-Bo; Liang, Tu-Liang; Ma, Lin-Rui; Wang, Jian; Wang, Xuan-Run; Fan, Xiao-Qing; Huang, Jie; Xie, Ying; Liu, Liang; Tang, Ling*; Leung, Elaine Lai-Han*; Yan, Pei-Yu*南方医科大学
Pharmacological Research2021-9DOI: 10.1016/j.phrs.2021.105574
27被引8阅读
引用收藏
分享

摘要

Currently, conventional methods of treating non-small cell lung cancer (NSCLC) have many disadvantages. An alternative effective therapy with minimal adverse reactions is urgently needed. Weijing decoction (WJD), which is a classic ancient Chinese herbal prescription, has been used successfully to treat pulmonary system diseases containing lung cancer in the clinic. However, the key active component and target of Weijing decoction are still unexplored. Therefore, for the first time, our study aims to investigate the pharmacological treatment mechanism of Weijing decoction in treating NSCLC via an integrated model of network pharmacology, metabolomics and biological methods. Network pharmacology results conjectured that Tricin is a main bioactive component in this formula which targets PRKCA to suppress cancer cell growth. Metabolomics analysis demonstrated that sphingosine-1-phosphate, which is regulated by sphingosine kinase 1 and sphingosine kinase 2, is a differential metabolite in plasma between the WJD-treated group and the control group, participating in the sphingolipid signaling. In vitro experiments demonstrated that Tricin had vital effects on the proliferation, pro-apoptosis, migration and colony formation of Lewis lung carcinoma cells. Through a series of validation assays, Tricin inhibited the tumor growth mainly by suppressing PRKCA/SPHK/S1P signaling and antiapoptotic signaling. On the other hand, Weijing formula could inhibit the tumor growth and prolong the survival time. A high dosage of Tricin was much more potent in animal experiments. In conclusion, we confirmed that Weijing formula and its primary active compound Tricin are promising alternative treatments for NSCLC patients.

学科与关键词

关键词
Weijing decoctionNon-small cell lung cancerNetwork pharmacologySphingolipid metabolismTricinProtein kinase C alpha (PRKCA)
相关
加载中…
  • Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments
    Peng, Huiting; Huang, Zhongming; Li, Peiqin; Sun, Zhe; Hou, Xuenan; Li, Zeyun; Sang, Ran; Guo, Zehuai; Wu, Siqi; Cao, Yang*Journal of Ethnopharmacology, 2024, 321: 117518.
  • Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer
    Cai, Jieqi; Chen, Yupeng; Wang, Kexin; Li, Yi; Wu, Jie; Yu, Hailang; Li, Qingping; Wu, Qi; Meng, Wei; Wang, Handuo; Lu, Aiping; Huang, Mianbo*; Wei, Genxia*; Guan, Daogang*BMC Complementary Medicine and Therapies, 2023, 23(1): 158.被引 2
  • Combinational study with network pharmacology, molecular docking and preliminary experiments on exploring common mechanisms underlying the effects of weijing decoction on various pulmonary diseases
    Li, Jia-Xin; Han, Zhong-Xiao; Cheng, Xin; Zhang, Feng-Lin; Zhang, Jing-Yi; Su, Zi-Jie; Li, Biao-Ping; Jiang, Zhi-Rui; Li, Run-Ze; Xie, Ying; Yan, Pei-Yu*; Tang, Ling*; Yang, Jia-Shun*Heliyon, 2023, 9(5): e15631.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmacological Research
发表日期
2021-09
卷期
第 171 卷
页码
105574
DOI
10.1016/j.phrs.2021.105574
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Science and Technology Development Fund, Macau SAR; Faculty Research Grant Projects of Macau University of Science and Technology [FRG-19-028-FC]; Dr. Neher's Biophysics Laboratory for Innovative Drug Discover [0096/2018/A3, 001/2020/ALC]

作者

  • L

    Li, Jia-Xin (第一作者)

  • L

    Li, Run-Ze

查看全部 20 位作者收起作者
  • S

    Sun, Ao

  • Z

    Zhou, Hua

  • N

    Neher, Erwin

  • Y

    Yang, Jia-Shun

    southern med univ

  • H

    Huang, Ju-Min

  • Z

    Zhang, Yi-Zhong

  • J

    Jiang, Ze-Bo

  • L

    Liang, Tu-Liang

  • M

    Ma, Lin-Rui

  • W

    Wang, Jian

  • W

    Wang, Xuan-Run

  • F

    Fan, Xiao-Qing

  • H

    Huang, Jie

  • X

    Xie, Ying

  • L

    Liu, Liang

  • T

    Tang, Ling (通讯)

    southern med univ

  • L

    Leung, Elaine Lai-Han (通讯)

  • Y

    Yan, Pei-Yu (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417